JP2007535548A5 - - Google Patents

Download PDF

Info

Publication number
JP2007535548A5
JP2007535548A5 JP2007510941A JP2007510941A JP2007535548A5 JP 2007535548 A5 JP2007535548 A5 JP 2007535548A5 JP 2007510941 A JP2007510941 A JP 2007510941A JP 2007510941 A JP2007510941 A JP 2007510941A JP 2007535548 A5 JP2007535548 A5 JP 2007535548A5
Authority
JP
Japan
Prior art keywords
methyl
isochroman
piperidin
aminomethyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007510941A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007535548A (ja
JP4685861B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/014487 external-priority patent/WO2005111025A1/en
Publication of JP2007535548A publication Critical patent/JP2007535548A/ja
Publication of JP2007535548A5 publication Critical patent/JP2007535548A5/ja
Application granted granted Critical
Publication of JP4685861B2 publication Critical patent/JP4685861B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007510941A 2004-04-29 2005-04-27 ドーパミンアゴニストとしての3−ピペリジニルイソクロマン−5−オール Expired - Fee Related JP4685861B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56655704P 2004-04-29 2004-04-29
PCT/US2005/014487 WO2005111025A1 (en) 2004-04-29 2005-04-27 3-piperidinylisochroman-5-ols as dopamine agonists

Publications (3)

Publication Number Publication Date
JP2007535548A JP2007535548A (ja) 2007-12-06
JP2007535548A5 true JP2007535548A5 (enExample) 2008-03-27
JP4685861B2 JP4685861B2 (ja) 2011-05-18

Family

ID=34967397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007510941A Expired - Fee Related JP4685861B2 (ja) 2004-04-29 2005-04-27 ドーパミンアゴニストとしての3−ピペリジニルイソクロマン−5−オール

Country Status (11)

Country Link
US (1) US7919508B2 (enExample)
EP (1) EP1749001B1 (enExample)
JP (1) JP4685861B2 (enExample)
AR (1) AR050245A1 (enExample)
AT (1) ATE459618T1 (enExample)
DE (1) DE602005019719D1 (enExample)
DK (1) DK1749001T3 (enExample)
ES (1) ES2342083T3 (enExample)
PT (1) PT1749001E (enExample)
TW (1) TW200607802A (enExample)
WO (1) WO2005111025A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX370104B (es) * 2013-10-22 2019-12-02 Chiesi Farm Spa Proceso para la preparacion de un inhibidor de fosfodiesterasa (pde4).
CA2946990A1 (en) * 2014-04-28 2015-11-05 Pfizer Inc. Heterocyclic compounds and their use as dopamine d1 ligands
HRP20201469T1 (hr) * 2014-10-08 2020-12-11 UCB Biopharma SRL Derivati tetrahidroizokinolina
JP7187437B2 (ja) * 2016-07-29 2022-12-12 サノビオン ファーマシューティカルズ インク 化合物および組成物ならびにそれらの使用
EP3490607A4 (en) * 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
JP7471818B2 (ja) 2016-08-18 2024-04-22 ヴィダック ファーマ リミテッド ピペラジン誘導体、医薬組成物、及びその使用方法
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
CN111196781B (zh) * 2018-11-16 2023-07-28 湖南中南制药有限责任公司 一种改进的制备五氟利多的方法
KR20210139376A (ko) 2019-03-14 2021-11-22 선오비온 파마슈티컬스 인코포레이티드 이소크로마닐 화합물의 염, 및 이의 결정성 형태, 제조방법, 치료 용도 및 약제학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994486A (en) * 1989-05-31 1991-02-19 Abbott Laboratories Dopaminergic compounds
US4963568A (en) * 1989-05-31 1990-10-16 Abbott Laboratories Dopamine agonists
WO1998034933A1 (en) * 1997-02-07 1998-08-13 Hoechst Marion Roussel, Inc. (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
US6004982A (en) * 1997-09-15 1999-12-21 Hoechst Marion Roussel, Inc. 4-piperidinyl) H-2-benzopyran derivatives useful as antipsychotic agents

Similar Documents

Publication Publication Date Title
JP6466171B2 (ja) 新規アミン誘導体またはその塩
KR102491308B1 (ko) Cyp11a1 (시토크롬 p450 모노옥시게나제 11a1) 억제제로서 피란 유도체
AU2012266369B2 (en) Pyridin- 2 -amides useful as CB2 agonists
KR101477553B1 (ko) 이소인돌론 화합물 및 대사성 글루타메이트 수용체증강제로서 이들의 용도
AU732863B2 (en) Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagonist activity
PT808312E (pt) Derivados de indolo antagonistas do receptor 5-ht
EP2033953A1 (en) Vanilloid receptor modulators
PT1492786E (pt) Piridinoilpiperidinas como agonistas do 5-ht1f
SK16152002A3 (sk) Farmacueticky účinné piperidínové deriváty, najmä ako modulátory aktivity chemokínového receptora
JP2006298893A5 (enExample)
BRPI0609062A2 (pt) composição farmacêutica, compostos, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por inibidores de deidrogenase de hidroxiesteróide-11ß e utilização dos compostos
KR20060095865A (ko) 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
CZ289998B6 (cs) Léčivo proti nachlazení nebo alergické rinitidě
EP1748980A1 (en) Pyrrolidine derivatives as cb1-receptor antagonists
CA2538381A1 (en) 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
JP2007535548A5 (enExample)
CA2525442A1 (en) Cyanofluoropyrrolidine derivatives
WO2014003124A1 (ja) 新規なアミド誘導体またはその塩
JPH09500124A (ja) 5‐ht1a受容体拮抗物質としてのn‐(ピペリジニル‐1‐アルキル)‐置換シクロヘキサンカルボン酸アミド
US20080306055A1 (en) Heterocyclic Mchr1 Antagonists And Their Use In Therapy
JPWO2009041559A1 (ja) インダゾールアクリル酸アミド化合物
JP2004504318A (ja) 置換1−(4−アミノフェニル)インドール類及びその抗炎症剤としての使用
JP5410536B2 (ja) 3−(ベンジルアミノ)−ピロリジン誘導体及びnk−3受容体アンタゴニストとしてのその使用
CN102834385B (zh) 1型11-β-羟基固醇脱氢酶的抑制剂化合物
CN1323297A (zh) 哒嗪酮衍生物